Evolus Announces Participation in November Investment Conferences
November 09, 2021 08:30 ET
|
Evolus
NEWPORT BEACH, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Reports Third Quarter 2021 Results and Provides Business Update
November 02, 2021 08:03 ET
|
Evolus
Record Quarter: U.S. Net Revenue Grew 58% Year-over-Year to $26.7 Million $107.8 Million Cash Position at Quarter-EndInitiated Jeuveau® “Extra Strength” Phase II Clinical Program to Demonstrate...
Evolus Initiates Phase II Program with “Extra Strength” Dose for Extended Duration
November 02, 2021 08:01 ET
|
Evolus
Program Designed to Offer Consumers an “Extra Strength” Dosing OptionEvolus is Uniquely Positioned to Capitalize on this Opportunity with the Company’s Aesthetics-Only Strategy and Jeuveau® Product...
Evolus Announces Appointment of Jessica Novak as Senior Vice President, Human Resources
November 01, 2021 16:10 ET
|
Evolus
NEWPORT BEACH, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus to Report Third Quarter 2021 Results and Provide Business Update
October 22, 2021 09:00 ET
|
Evolus
NEWPORT BEACH, Calif., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Announces Participation in September Investment Conferences
September 02, 2021 09:00 ET
|
Evolus
NEWPORT BEACH, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Reports Second Quarter 2021 Results and Provides Business Update
August 04, 2021 16:05 ET
|
Evolus
Record Quarter: Net Revenue Grew 235% Year-over-Year to $26.1 Million Exceeded Annualized Revenue Run Rate Goal of $100 Million Low Q2 Cash Burn Resulting in $131.7 Million Cash Position at...
Evolus to Report Second Quarter 2021 Results and Provide Business Update
July 22, 2021 09:00 ET
|
Evolus
NEWPORT BEACH, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Announces Appointment of David K. Erickson as Vice President, Investor Relations
June 30, 2021 09:00 ET
|
Evolus
NEWPORT BEACH, Calif., June 30, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Peer Reviewed Article Highlights Efficacy and Safety of Jeuveau® in Patients with Skin of Color
June 24, 2021 09:00 ET
|
Evolus
NEWPORT BEACH, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...